BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21744039)

  • 1. Glycopeptide resistance in coagulase-negative staphylococci isolated in blood cultures from patients with hematological malignancies during three decades.
    Ahlstrand E; Svensson K; Persson L; Tidefelt U; Söderquist B
    Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1349-54. PubMed ID: 21744039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous glycopeptide intermediate Staphylococcus epidermidis isolated from prosthetic joint infections.
    Tevell S; Claesson C; Hellmark B; Söderquist B; Nilsdotter-Augustinsson Å
    Eur J Clin Microbiol Infect Dis; 2014 Jun; 33(6):911-7. PubMed ID: 24338092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
    Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Gaona Álvarez C; Sánchez Silos RM; Hernández Rastrollo R; Martínez Tallo E; Cordero Carrasco JL
    Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides.
    Del' Alamo L; Cereda RF; Tosin I; Miranda EA; Sader HS
    Diagn Microbiol Infect Dis; 1999 Jul; 34(3):185-91. PubMed ID: 10403098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of Staphylococcus strains with heterogeneous resistance to glycopeptides in a Turkish university hospital.
    Nakipoglu Y; Derbentli S; Cagatay AA; Katranci H
    BMC Infect Dis; 2005 May; 5():31. PubMed ID: 15871748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycopeptide resistance in coagulase-negative staphylococci.
    Biavasco F; Vignaroli C; Varaldo PE
    Eur J Clin Microbiol Infect Dis; 2000 Jun; 19(6):403-17. PubMed ID: 10947214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of teicoplanin in the treatment of bloodstream infection caused by methicillin-resistant coagulase-negative staphylococci.
    Yamada K; Ueda T; Nakajima K; Ichiki K; Tsuchida T; Otani N; Takahashi Y; Ikeuchi H; Uchino M; Koshiba M; Takesue Y
    J Infect Chemother; 2020 May; 26(5):459-464. PubMed ID: 31870587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous resistance to vancomycin in Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus warneri clinical strains: characterisation of glycopeptide susceptibility profiles and cell wall thickening.
    Nunes AP; Teixeira LM; Iorio NL; Bastos CC; de Sousa Fonseca L; Souto-Padrón T; dos Santos KR
    Int J Antimicrob Agents; 2006 Apr; 27(4):307-15. PubMed ID: 16542825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing susceptibilities of coagulase-negative staphylococci to teicoplanin in a teaching hospital.
    Sloos JH; van de Klundert JA; Dijkshoorn L; van Boven CP
    J Antimicrob Chemother; 1998 Dec; 42(6):787-91. PubMed ID: 10052903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of vancomycin, ciprofloxacin, daptomycin, and linezolid against coagulase-negative staphylococci bacteremia.
    Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Rodríguez-Vidigal FF; Vera Tomé A; Robles Marcos M
    Rev Esp Quimioter; 2011 Jun; 24(2):74-8. PubMed ID: 21666998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro induction of resistance in coagulase-negative staphylococci to vancomycin and teicoplanin.
    Watanakunakorn C
    J Antimicrob Chemother; 1988 Sep; 22(3):321-4. PubMed ID: 2972670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European Glycopeptide Susceptibility Survey of gram-positive bacteria for 1995. European Glycopeptide Resistance Survey Study Group.
    Felmingham D; Brown DF; Soussy CJ
    Diagn Microbiol Infect Dis; 1998 Aug; 31(4):563-71. PubMed ID: 9764397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of reduced susceptibility to glycopeptides among methicillin-resistant Staphylococcus aureus isolates from patients in Ireland and evaluation of agar screening methods for detection of heterogeneously glycopeptide-intermediate S. aureus.
    Fitzgibbon MM; Rossney AS; O'Connell B
    J Clin Microbiol; 2007 Oct; 45(10):3263-9. PubMed ID: 17687008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative in vitro activity of glycopeptides against coagulase negative staphylococci isolated in pediatric hospital units].
    Bourgeois F; Bingen E; Lambert-Zechovsky N
    Pathol Biol (Paris); 1992 Jan; 40(1):36-9. PubMed ID: 1533278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidis.
    Garrett DO; Jochimsen E; Murfitt K; Hill B; McAllister S; Nelson P; Spera RV; Sall RK; Tenover FC; Johnston J; Zimmer B; Jarvis WR
    Infect Control Hosp Epidemiol; 1999 Mar; 20(3):167-70. PubMed ID: 10100541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a new Etest vancomycin-teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA), in particular, heterogeneous GISA.
    Yusof A; Engelhardt A; Karlsson A; Bylund L; Vidh P; Mills K; Wootton M; Walsh TR
    J Clin Microbiol; 2008 Sep; 46(9):3042-7. PubMed ID: 18596146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycopeptide resistance in Enterococcus spp. and coagulase-negative staphylococci from hospitalised patients in Germany: occurrence, characteristics and dalbavancin susceptibility.
    Kresken M; Klare I; Wichelhaus TA; Wohlfarth E; Layer-Nicolaou F; Neumann B; Werner G;
    J Glob Antimicrob Resist; 2022 Mar; 28():102-107. PubMed ID: 34958996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methicillin-resistant staphylococcal bacteremia in patients with hematologic malignancies: clinical and microbiological retrospective comparative analysis of S. haemolyticus, S. epidermidis and S. aureus.
    Falcone M; Micozzi A; Pompeo ME; Baiocchi P; Fabi F; Penni A; Martino P; Venditti M
    J Chemother; 2004 Dec; 16(6):540-8. PubMed ID: 15700845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of daptomycin and tigecycline against coagulase-negative staphylococcus blood isolates from bone marrow transplant recipients.
    Kratzer C; Rabitsch W; Hirschl AM; Graninger W; Presterl E
    Eur J Haematol; 2007 Nov; 79(5):405-9. PubMed ID: 17714506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative activities of daptomycin and several agents against staphylococcal blood isolates. Glycopeptide tolerance.
    Picazo JJ; Betriu C; Rodríguez-Avial I; Culebras E; López-Fabal F; Gómez M;
    Diagn Microbiol Infect Dis; 2011 Jul; 70(3):373-9. PubMed ID: 21683269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.